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Abstract
Background: Changes in glutamatergic neurotransmission via decreased glutamate transporter (GLT) activity or
expression contributes to multiple neurological disorders. Chemokines and their receptors are involved in
neurological diseases but the role of chemokines in the expression of glutamate transporters is unclear.
Methods: Primary astrocytes were prepared from neonatal (<24 hours old) SJL/J mouse brains and incubated with
5 μg/ml lipopolysaccharide (LPS) or 50 ng/ml tumor necrosis factor α (TNF-α) for 24 hours. Soluble macrophage
inflammatory protein-2γ (MIP-2γ) in culture supernatants was determined using a sandwich ELISA. The MIP-2γ effect
on the expression of GLT-1 was measured by quantitative RT-PCR, flow cytometric analysis or western blot assay.
Detergent-resistant membranes from astrocytes were isolated on the basis of their ability to float in density
gradients. Raft-containing fractions were tracked by the enrichment of caveolin-1 and the dendritic lipid raft marker,
flotillin-1. Cell viability was determined by measuring either the leakage of lactate dehydrogenase or the reduction
of 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide by viable cells and confirmed by visual inspection.
Results: The production of the chemokine MIP-2γ by mouse cortical astrocytes increased significantly after
stimulation with LPS or TNF-α in vitro. Astrocytes over-expressing MIP-2γ down-regulated the expression of GLT-1 at
the mRNA and protein level and caused redistribution of GLT-1 out of the lipid rafts that mediate glutamate uptake.
We used pharmacological inhibitors to identify the downstream signaling pathways underlying MIP-2γ activity. We
also found complementary results by knocking down MIP-2γ activity in astrocytes with MIP-2γ small interfering RNA
(siRNA). MIP-2γ overexpression in astrocytes enhanced the neuronal toxicity of glutamate by decreasing GLT-1
activity, but MIP-2γ itself was not toxic to neurons.
Conclusions: These results suggest that MIP-2γ mediates the pathogenesis of central nervous system disorders
associated with neutrophil infiltration in the brain and decreased GLT-1 activity.
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Background
Glutamate is the major excitatory neurotransmitter in
the mammalian central nervous system (CNS). At high
extracellular levels, this excitatory amino acid is an ex-
tremely potent neurotoxin. Extracellular glutamate con-
centrations in the CNS are regulated by a family of
high-affinity, Na+-dependent glutamate transporters.
Five subtypes of transporters, EAAT1–EAAT5 (excita-
tory amino acids transporters 1–5), have been identi-
fied, two of which, the glutamate transporter GLT-1
(also known as EAAT-2) and glutamate-aspartate
transporter GLAST (also known as EAAT-1 or GLT-
2), are predominantly present on astrocytes and are
the major glutamate transporters in the CNS [1]. Mal-
function or aberrant expression of these glutamate
transporters can cause accumulation of toxic concen-
trations of glutamate and trigger neurodegeneration.
Reduced GLT-1 protein expression occurs in brain injury
or ischemia, Alzheimer’s disease, Huntington’s disease,
HIV-1-associated dementia (HAD), and experimental
autoimmune encephalomyelitis (EAE) [2-5]. In EAE, for
example, GLT-1 and GLAST proteins are down-
regulated in the spinal cord at the peak of disease symp-
toms, with no recovery in expression after remission.
These data emphasize the importance of the astrocyte
GLT-1 transporter for normal brain function and its con-
tribution to multiple CNS pathologies.
Astrocytes are often associated with the pathogenesis
of infectious and immune inflammatory responses in-
volving the CNS and are a major source of chemokines,
such as monocyte chemoattractant protein-1 (MCP-1),
macrophage inflammatory protein-1α (MIP-1α), inflam-
matory protein-10 (IP-10), RANTES and MIP-2 [6,7].
Proinflammatory mediators such as lipopolysaccharide
(LPS), tumor necrosis factor α (TNF-α), and IL-1 induce
astrocytes to release many of these chemokines in vitro
[8,9]. Chemokines and their receptors are involved in
neurological diseases, including multiple sclerosis, Alz-
heimer’s disease, HAD, and cerebral ischemia [10-12].
However, the role of chemokines in the expression of
glial glutamate transporters is unclear.
A novel CXC chemokine, MIP-2γ (also known as
CXCL14) was identified and characterized from a human
dendritic cell (DC) cDNA library [13]. MIP-2γ mRNA is
widely and constitutively expressed in normal tissues, in-
cluding the brain. MIP-2γ exhibited potent chemotaxis
on neutrophils, was less active on DCs, and inactive on
monocytes, NK cells, and T and B lymphocytes [13]. We
found that MIP-2γ mRNA expression within the CNS of
EAE mice varied at the onset, peak, remission, and re-
lapse [14]. But the origin and role of MIP-2γ in inflam-
matory disorders of the brain are still unclear.
Therefore, we analyzed the effect of MIP-2γ on GLT-1
and GLAST expression in astrocytes, as well as their
redistribution into functional raft microdomains. We
also measured changes in glutamate uptake in response
to MIP-2γ overexpression and dissected the MIP-2γ sig-
naling pathways. Finally, we evaluated whether MIP-2γ




The mouse wild-type MIP-2γ cDNA [13] was subcloned
into pAAV-IRES-hrGFP (Stratagene, La Jolla, CA, USA)
to create the MIP-2γ expression vector, pAAV-MIP-2γ-
hrGFP. MIP-2γ cDNA sequences were confirmed by
DNA sequencing. To construct an RNAi vector to si-
lence the MIP-2γ gene, we designed and synthesized
three double-stranded oligonucleotides targeting three
different sites of the MIP-2γ cDNA (position 440–460,
465–485 and 574–594, AF252873) that could generate
hairpin small interfering RNAs (siRNA-1, siRNA-2 and
siRNA-3, respectively). The selection of the coding
sequences for siRNA was analyzed by BLAST to ensure
that they did not have significant sequence homology
with other genes. Then, the oligonucleotides were
inserted into pBS/U6 (gift of Yang Shi, Harvard Medical
School, Boston, MA, USA) according to the method of
Sui et al. [15]. After confirmation by sequencing, RNAi
vectors were transfected into astrocytes with Polyfect
(QIAGEN, Valencia, CA, USA) according to the manu-
facturer’s instructions. The negative control plasmid
(pBS/U6-con) contains a scrambled sequence (GCTGTC
TGATCAATGGACGAC) that does not show significant
homology to mouse gene sequences.
Cell culture and treatment
Primary astrocytes were prepared from neonatal (<24-
hours old) SJL/J mouse brains using methods similar
to those described previously [16,17]. Primary glial cell
cultures were maintained in (D)MEM (Gibco, Carlsbad,
CA, USA) supplemented with 10% FCS, 6 mg/ml glu-
cose, and 5 μg/ml bovine pancreas insulin (Sigma-
Aldrich, St. Louis, MO, USA), referred to as complete
medium, in 10% CO2 at 37°C. After 11 days, the flasks
were agitated on an orbital shaker for 14 hours at
250 rpm at 37°C, and the nonadherent oligodendrocyte
and microglial cells were removed. Cortical astrocytes
were purified from the primary mixed glial cell culture
by three to four repetitions of trypsinization and
replating. The purity of astrocytes was more than 95%
when determined by indirect immunofluorescence
using an anti-glial fibrillary acid protein (GFAP) anti-
body. To increase surface expression of glutamate
transporters, astrocyte cultures were treated with
250 μM dibutyryl cAMP (dBcAMP) (Sigma) for 7 days
before experimentation.
Fang et al. Journal of Neuroinflammation 2012, 9:267 Page 2 of 12
http://www.jneuroinflammation.com/content/9/1/267
Neuron cultures were prepared from SJL/J mice at em-
bryonic day 17. In brief, the cortices were dissected and
freed of meninges. Cortical fragments were incubated
with 0.25% trypsin and 20 μg/ml DNase I in PBS at 37°C
for 15 minutes. The cortical fragments were then disso-
ciated into single cells by pipetting, and the cells were
suspended in Neurobasal-A medium containing a B27
serum-free supplement (Invitrogen, Grand Island, NY,
USA) and plated onto poly-D-lysine (50 μg/ml)-coated
plates. Twenty-four hours later, the cultures were treated
with 5 μM cytosine arabinoside (Sigma) in vitro for
72 hours to prevent proliferation of other cell types.
More than 95% of the cells were positive for staining
with the neuron-specific microtubule-associated protein
2 (MAP-2) antibody (Sigma).
Induction with LPS and TNF-α was performed on
1×106/ml astrocytes cultured for 24 hours with or with-
out 5 μg/ml LPS or 50 ng/ml TNF-α, with the superna-
tants collected for an MIP-2γ ELISA assay and the
remaining cells washed three times with PBS and col-
lected for RNA or protein extraction. Astrocytes (1×106/
ml) were transfected with the plasmid pAAV-IRES-
hrGFP or the plasmid pAAV-MIP-2γ-hrGFP alone or
combined with either the pBS/U6 vector or the plasmid
MIP-2γ siRNA using Polyfect (QIAGEN) according to
the manufacturer’s instructions. Media were collected
three days after transfection and the remaining cells
were washed three times with PBS for RNA or protein
extraction. The plasmid pAAV-IRES-hrGFP containing
the hrGFP gene was used as a control for transient
transfection. The expression of hrGFP by astrocytes was
analyzed by fluorescence microscopy (Leica, Deerfield,
IL, USA) using a ×20 objective, and the data were
acquired with a Sony digital charge-coupled device cam-
era and processed by Adobe PHOTOSHOP software.
For neuron/astrocyte (N/A) co-culture experiments,
neurons were plated as normal in 24-well trays and
maintained in culture for 11 days before addition of
astrocytes. Transfected or untransfected astrocytes were
plated in tissue culture inserts (BD Falcon, Franklin
Lakes, NJ, USA) at 104 cells/insert with 3.0 μm pores.
Before assaying neuron survival, the inserts were
removed and 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl-
tetrazolium bromide (MTT; Sigma) assays or lactate de-
hydrogenase (LDH) release tests were performed on the
neurons. Immunostaining against the cytoskeleton con-
stituent, MAP-2, confirmed their neuron identity.
MIP-2γ ELISA
Secreted, soluble MIP-2γ in culture supernatants was deter-
mined using a sandwich ELISA with a monoclonal anti-
mouse MIP-2γ antibody [13]. The captured antibody was
used at 1 μg/ml and the biotinylated detection antibody
was used at 400 ng/ml (R&D Systems Inc. Minneapolis,
MN, USA).
Detergent-free isolation of lipid rafts
Detergent-resistant membranes from astrocytes were
isolated on the basis of their insolubility in Triton X-100
at 4°C and their ability to float in density gradients as
described previously [18,19]. Astrocytes were homoge-
nized in a homogenizer in 1.5 ml of PTN 50 buffer
(50 mM sodium phosphate, pH 7.4, 1% Triton X-100,
50 mM NaCl) containing 10 mM dithiotheritol, 1 mM
phenylmethylsulfonyl fluoride, 5 μg/ml leupeptin, and
1 μg/ml pepstatin A, and centrifuged at 12,000 rpm for
3 minutes. The supernatant was placed at the bottom of
an ultracentrifugation tube and mixed with an equal vol-
ume of 80% (w/v) sucrose. The samples were overlaid
with 30% (w/v) and 5% (w/v) sucrose, respectively. The
gradient was centrifuged at 55,000 rpm for 2 hours at
4°C with a TLS 55 Beckmann swing rotor. Ten fractions
were collected from the top of the gradient and protein
levels quantified. An equal volume of each fraction
(30 μl) was diluted in a loading buffer and used for im-
munoblotting. Fractions corresponding to raft microdo-
mains (fraction numbers 3, 4 and 5) and fractions
corresponding to detergent-soluble material (fraction
numbers 8, 9 and 10) were pooled before loading on the
same acrylamide gel. Six wells were pooled for each con-
dition, and only the fractions corresponding to raft and
soluble proteins were studied. Raft-containing fractions
were tracked by the enrichment of the cholesterol bind-
ing protein, caveolin-1, and the dendritic lipid raft mar-
ker, flotillin-1.
RT-PCR and real-time quantitative PCR analysis
The primer sets used in RT-PCR for MIP-2γ, GLT-1,
GLAST, GFAP, and β-actin were designed with Oligo soft-
ware (Table 1). Total RNA was isolated from astrocytes
using Trizol reagent (Life Technologies, Carlsbad, CA,
USA). A total of 20 μg of RNA was reverse-transcribed by
using 200 U per μl of Moloney murine leukemia virus
(Promega, Madison, WI, USA) and 2 μg of random hex-
amer primers (Interactiva, Ulm, Germany). Obtained
templates were amplified in a final volume of 50 μl. Cyc-
ling conditions comprised an initial denaturation of
3 minutes at 94°C followed by 30 cycles of amplification
(at 94°C for 40 seconds, 50°C for 45 seconds and 72°C
for 1 minute) and final elongation step at 72°C for
10 minutes in the presence of 20 pmol of primers. Reac-
tion products were separated and visualized with eth-
idium bromide on a 1.5% agarose gel. Real-time PCR was
performed in the Applied Biosystems 7500 Real-Time
PCR System software using SYBR GREEN PCR Master-
Mix (Qiagen). PCR was performed under the following
conditions: initial denaturation at 95°C for 15 minutes
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and 37 cycles of 95°C for 30 seconds, 60°C for 30 sec-
onds, and 72°C for 20 seconds. The generation of
specific PCR products was confirmed by melting curve
analysis. Each reaction was run in triplicate. The ex-
pression of GLT-1 was normalized against β-actin by
the comparative threshold cycle (ct) method using the
following formula: fold difference in expression = 2–(Δct
of target gene–Δct of reference). Primer sequences for real
time PCR were: GLT-1, 50-GGCAATCCCAAACTCAA
GAAGC-30 (forward) and 50-GTCACTGTCTGAATCT
GCTGGAAAC-30 (reverse); β-actin, 50-GCCAACACA
GTGCTGTCT-30 (forward), and 50-AGGAGCAATGAT
CTTGATCTT-30 (reverse).
Western blotting
Whole cells were homogenized in radioimmunoprecipi-
tation assay buffer (PBS, 0.1% sodium dodecyl sulfate
(SDS), 1% NP-40, 0.5% sodium deoxycholate) and pro-
tein concentrations of the samples determined by the
bicinchoninic acid method (Pierce) using BSA as a
standard. Equal amounts of total protein (5 to 8 μg)
were adjusted to similar volumes with loading buffer
(10% SDS, 20% glycerin, 125 mM Tris, 1 mM ethylene-
diaminetetraacetic acid, 0.002% bromphenol blue, 10%
β-mercapto-ethanol), denatured by heating at 95°C for
5 minutes, subjected to 10% SDS-PAGE, and then electro-
blotted onto a nitrocellulose membrane (Amersham) using
a minigel and mini transblot apparatus (Bio-Rad, Hercules,
CA, USA). The membranes were blocked with 5% nonfat
dry milk in TBST buffer (25 mM Tris–HCl pH 8.0,
125 mM NaCl, and 0.1% Tween 20) for 1 hour at
room temperature. The blots were then incubated
with either anti-MIP-2γ (1:500; R&D Systems), anti-
GLT-1 (1:1000; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA, USA), anti-GLAST (1:1000; Santa Cruz
Biotechnology), anti-GFAP (1:500; Dako, Glostrup,
Denmark), anti-flotilin-1 (1:500; Transduction Laborator-
ies, San Diego, CA, USA), anti-caveolin-1 (1:500; Trans-
duction Laboratories), or anti-β-actin (1:1000; Santa Cruz
Biotechnology) antibodies diluted in TBS/Tween overnight
at 4°C. The blots were incubated with the appropriate
horseradish peroxidase-conjugated secondary antibodies
(Jackson Immuno-Research, West Grove, PA, USA) for
1.5 hours at room temperature. Membrane-bound second-
ary antibodies were detected using the chemiluminescence
Super Signal procedure (Pierce) according to the manufac-
turer’s instructions.
Flow cytometric analysis of GLAST and GLT-1
Cells (1 × 107 cells/ml) were washed twice with PBS,
preincubated in PBS/1% BSA (Sigma) for 1 hour at
4°C, and then incubated with unconjugated rabbit
polyclonal anti-GLAST and anti-GLT-1 antibodies for
1 hour at 4°C. Subsequently, cells were washed once
with PBS/0.1%BSA and stained with fluorescein
isothiocyanate-conjugated goat anti-rabbit immuno-
globulin G (IgG) (Molecular Probes, Eugene, OR, USA)
for 30 minutes. The fluorescence intensity of cells was
measured using FACScan (Becton Dickinson, Mountain
View, CA, USA).
[3H]-glutamate uptake assay
L-[3H] glutamate uptake was determined by the method
described by Lee and coworkers (19). In brief, after
transfection and supernatant collection, the medium was
replaced by 0.5 ml of fresh medium containing 30 μM
unlabeled glutamate and 0.025 μCi/ml L-[3H]-glutamate
(10 nM, 45.0 Ci/mmol; Amersham Biosciences, Bucking-
hamshire, UK). Uptake was terminated 10 minutes later
by removing the supernatant and washing the cells three
times with 2 ml of ice-cold PBS containing 5 mM glu-
tamate. Astrocytes were then lysed by 0.5 ml of 1 N
NaOH containing 0.1% Triton X-100, and a 300-μl por-
tion was assayed for 3H by liquid scintillation counting.
The protein content was measured by Lowry’s protein
assay using BSA standards in 100 μl of the remaining
lysate. Uptake was expressed as cpm per minigram of
cellular proteins.
Table 1 RT-PCR primers and predicted product length
mRNA Primer sequence Primer length (bp) Product length (bp)
MIP-2γ Forward 5'-GCGCGTTGGACGGGTCCAAGT-3' 21 200
Reverse 5'-GCGAGCACCAAACGCTTCATC-3' 21
GLT-1 Forward 5'-TTCCAGTCTCATCACAGGGCT-3' 21 463
Reverse 5'-GCCGAAAGCAATAAAGAATCC-3' 21
GLAST Forward 5'-TAAGTATCACAGCCACAGCCG-3' 21 454
Reverse 5'-GAGTAGGGAGGAAAGAGGAG-3' 20
GFAP Forward5'-AGTTACCAGGAGGCACTTGCT-3' 21 484
Reverse 5'- TCCTGTTCTATACGCAGCCAG-3' 21
β-actin Forward 5'-ATCCGTAAAGACCTCTATGC-3' 20 287
Reverse 5'-AACGCAGCTCAGTAACAGTC-3' 20
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Cell viability assay
Neurons were co-cultured with untransfected or trans-
fected astrocytes for 4 days; after this time, glutamate
(50 μM) was added. After 4 hours, the inserts containing
the astrocytes were discarded and neuronal survival was
determined by measuring either the leakage of LDH
from dead or dying cells into the culture medium or the
reduction of MTT by viable cells and confirmed by vis-
ual inspection.
Astrocyte conditioned media (AM) derived from dif-
ferent groups was collected and used without freezing by
direct application on neuronal cultures. Primary cortical
neuronal cultures were seeded onto 96-well plates at
5,000 cells per well in B27-supplemented medium in the
presence or absence of different AM (20% to 80% v/v)
for 4 days. Medium was then replaced with fresh B27-





























Figure 1 Relative MIP-2γ mRNA and protein expression in
astrocytes. (a) RT-PCR analysis of MIP-2γ expression in purified
primary astrocyte cultures. Levels of MIP-2γ mRNA were increased in
primary cultures of astrocytes exposed to LPS or TNF-α compared
with buffer-treated astrocytes (control). β-actin was used as a
positive control. (b) MIP-2γ is up-regulated after exposure to LPS or
TNF-α, shown by an ELISA for MIP-2γ in the conditioned media of
astrocytes. Data are expressed as the mean ± SEM from three to
four independent experiments. *P <0.05; **P <0.01 significantly
different from buffer-treated control (ANOVA followed by a
Dunnett’s test). (c) Representative western blot probed for MIP-2γ
and β-actin simultaneously. Levels of MIP-2γ in cell lysates derived
from primary astrocytes exposed to LPS or TNF-α were increased
compared with buffer-treated astrocytes (control). ANOVA, analysis
of variance, LPS, lipopolysaccharide; MIP-2γ, macrophage
inflammatory protein-2γ; SEM, standard error of the mean; TNF-α,
tumor necrosis factor α.
Figure 2 Specific knockdown of MIP-2γ expression in cultured
astrocytes by siRNA. Representative western blots of MIP-2γ and
GFAP. The expression of MIP-2γ was significantly increased after
pAAV-MIP-2γ-hrGFP transfection (MIP-2γ) compared with untreated
cultures (control) or transfected with pAAV-IRES-hrGFP (mock) vector.
This increase in MIP-2γ was inhibited by co-transfection with MIP-2γ
siRNAs (MIP-2γ + siRNA-1, MIP-2γ + siRNA-2, and MIP-2γ + siRNA-3),
but not by pBS/U6-con (MIP-2γ + BS/U6-con) vector. No significant
changes in GFAP occurred. Equal loading was confirmed by
exposing the membranes to an anti β-actin antibody. One of four
experiments that generated the same result is shown. GFAP, glial
fibrillary acid protein; MIP-2γ, macrophage inflammatory protein-2γ;
siRNA, small interfering RNA.
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4 hours later the cell viability was determined. LDH ac-
tivity was evaluated by using a commercially available kit
(Roche Molecular Biochemicals, Mannheim, Germany)
according to the manufacturer’s directions. In parallel
experiments, cell viability was assessed by an immuno-
cytochemistry analysis using a MAP-2 antibody to detect
neurons.
Immunocytochemistry
Immunocytochemistry was performed as previously
described [20]. Cells plated on sterile glass coverslips
coated with poly-d-lysine (50 μg/mL) were fixed with 4%
paraformaldehyde in PBS. After incubation with primary
antibodies (anti-GFAP 1:100 and anti-MAP-2 1:100;
Sigma) overnight at 4°C, coverslips were washed with
Figure 3 GLT-1 expression is down-regulated by MIP-2γ in primary cortical astrocytes. (a) Levels of GLT-1 mRNA were decreased in
primary astrocytes transfected with pAAV-MIP-2γ-hrGFP plasmids (MIP-2γ) compared with untreated cultures (control) or transfected with pAAV-
IRES-hrGFP (mock) vector. MIP-2γ knockdown with siRNA-1 (MIP-2γ + siRNA-1), but not with pBS/U6-con (MIP-2γ + BS/U6-con) inhibits this down-
regulation of GLT-1. No significant changes in GLAST, GFAP or β-actin occurred. (b) Representative western blot probed for GLT-1, GLAST, GFAP,
and β-actin simultaneously. Levels of GLT-1 in astrocytes transfected with pAAV-MIP-2γ-hrGFP plasmids (MIP-2γ) decreased compared with
untreated cultures (control) or transfected with pAAV-IRES-hrGFP (mock) vector, which could be partly reversed in astrocytes co-transfected with
siRNA-1 (MIP-2γ + siRNA-1) but not with pBS/U6-con (MIP-2γ + BS/U6-con). Levels of GLAST and GFAP were unaffected in all groups. To ensure
equal protein loading, blots were reprobed with β-actin-specific antibodies. (c) FACS analysis of GLAST or GLT-1 surface expression on astrocytes.
Binding of GLAST or GLT-1 (shadow) compared with that of a rat isotype control IgG (dashed line) to intact untreated cultures (control),
transfected with pAAV-IRES-hrGFP (mock) vector, transfected with pAAV-MIP-2γ-hrGFP plasmids (MIP-2γ), or pAAV-MIP-2γ-hrGFP plasmids co-
transfected with siRNA-1 (MIP-2γ + siRNA-1) or pBS/U6-con (MIP-2γ + BS/U6-con) astrocytes. FACS, fluorescence-activated cell sorting; GFAP, glial
fibrillary acidic protein; GLAST, glutamate-aspartate transporter; GLT-1, glutamate transporter; IgG, immunoglobulin G; MIP-2γ, macrophage
inflammatory protein-2γ; siRNA, small interfering RNA.
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blocking buffer and incubated with anti-mouse IgG-
fluorescein conjugates and then subjected to immu-
nofluorescent microscope analysis. The number of
immunolabeled cells was counted manually on fluores-
cence microscopic images by three independent indivi-
duals. All cell countings were location-matched between
each well. One frame for the visual field of 100 ×
100 μm was used for cell counting. Three different visual
fields were chosen randomly. Average values of cell
counts were calculated from the pooled data.
Results
Inflammatory stimuli increase the expression of MIP-2γ in
cultured mouse cortical astrocytes
We examined the ability of astrocytes to produce and re-
spond to inflammatory stimuli in vitro. Total RNA was
extracted from cortical astrocytes that were exposed to
LPS (5 μg/ml) or TNF-α (50 ng/ml) for 6, 12, or
24 hours, and subjected to cDNA synthesis and RT-PCR
analysis using primers for MIP-2γ and β-actin (Table 1).
RT-PCR analysis revealed that buffer-treated astrocytes
expressed messages for the housekeeping gene, β-actin,
and traces of MIP-2γ, whereas LPS and TNF-α treat-
ment increased MIP-2γ expression (Figure 1a, 1b).
Immunoblot analysis also showed that LPS and TNF-α
increased MIP-2γ protein expression in astrocytes
(Figure 1c).
Specific knockdown MIP-2γ expression in cultured
astrocytes by siRNA
We first examined the efficiency of astrocyte transduc-
tion using a pAAV-MIP-2γ-hrGFP vector, and at least
80% produced robust green fluorescence within two to
three days that did not diminish (for at least two weeks,
data not shown, replicated in at least three independent
experiments). We then used a siRNA to block MIP-2γ
expression. Astrocytes were cultured on 6-well plates
and transfected with either MIP-2γ siRNAs or the pBS/
U6-con vector together with pAAV-MIP-2γ-hrGFP
24 hours after plating. At 48 hours post-transfection, cell
extracts were assayed by immunoblotting for MIP-2γ
protein. Transfection with siRNAs directed at specific
MIP-2γ mRNA sequences suppressed MIP-2γ protein, es-
pecially MIP-2γ siRNA-1 (Figure 2), whereas transfection
Figure 4 Overexpression of MIP-2γ inhibits GLT-1 expression in lipid rafts and increases caveolin-1 expression. Equal amounts of
proteins from collected fractions were separated by SDS-PAGE and analyzed by immunoblotting using antibodies against GLT-1, GLAST, flotillin-1,
and caveolin-1. Raft domains (R) are recovered in low-density fractions 3, 4 and 5, which are enriched in flotilin-1, a component of lipid rafts.
Fractions 8, 9, and 10 correspond to detergent-soluble material (S). Co-fractionation of GLAST and GLT-1 with the lipid raft marker flotillin-1 and
caveolin-1 after sucrose density ultracentrifugation. Control, untreated cultures. Mock, astrocytes transfected with pAAV-IRES-hrGFP vector. MIP-2γ,
astrocytes transfected with pAAV-MIP-2γ-hrGFP plasmids. GLAST, glutamate-aspartate transporter; GLT-1, glutamate transporter; IgG,
immunoglobulin G; MIP-2γ, macrophage inflammatory protein-2γ.
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with the pBS/U6-con did not. In addition, transfection with
MIP-2γ siRNAs did not dramatically change levels of
GFAP, a marker for astrocyte activation, suggesting that
astrocyte function was not disrupted.
MIP-2γ decreases astrocyte expression of GLT-1
Treatment of astrocytes with dBcAMP increases both
GLT-1 and GLAST expression [16]. Our astrocyte cul-
tures are routinely cultured with 250 μM dBcAMP, so
GLAST and GLT-1 are both expressed (data not shown).
Transfection with pAAV-MIP-2γ-hrGFP reduced GLT-1
expression but not GLAST, and this decrease could be
partly reversed by MIP-2γ siRNA-1 (Figure 3a).
Flourescence- activated cell sorting analysis showed that
transfection of pAAV-MIP-2γ-hrGFP decreased cell-
surface GLT-1 expression, which was again partly
reversed by MIP-2γ siRNA-1, but did not affect GLAST
expression (Figure 3b). Western blots also showed that
MIP-2γ overexpression decreased total cellular GLT-1
expression but not GLAST expression (Figure 3c). The
actin band provides an index of intracellular proteins
present in each preparation, and the cytoskeletal protein,
GFAP, confirms the cells are astrocytes.
GLT-1 molecules are organized on lipid rafts in astro-
cytes, which may be necessary for efficient glutamate up-
take [18,19]. To isolate these rafts, we performed sucrose
gradient ultracentrifugation of detergent-free cell extracts
of MIP-2γ-transfected cells in the presence or absence of
MIP-2γ siRNA-1 plasmids (48 hours). Immunoblots of
pooled fractions corresponding to the raft domains, as
confirmed by the presence of the protein, flotillin-1, and
detergent-soluble material showed that both GLAST and
GLT-1 were recovered in rafts (Figure 4). MIP-2γ overex-
pression reduced levels of GLT-1 in the raft domains,
but did not affect GLAST recruitment into raft domains
(Figure 4). Interestingly, MIP-2γ overexpression in-
creased caveolin-1 levels but did not affect flotilin-1
levels (Figure 4), suggesting that the down-regulation of
GLT-1 was specific.
Effects of MIP-2γ on glutamate transport activity
We next measured the uptake of [3H]glutamate in astro-
cytes to determine whether the changes in GLT-1 ex-
pression had functional consequences. Na+-dependent
accumulation of glutamate was measured in untreated
astrocytes and in astrocytes overexpressing MIP-2γ in
the presence or absence of MIP-2γ siRNA-1 (48 hours).
MIP-2γ expression decreased [3H] glutamate uptake by
about 45% (Figure 5).
Signaling events linking MIP-2γ overexpression to GLT-1
reduction
We next used signaling pathway-specific inhibitors to
determine which pathways mediated the decreases in
GLT-1 protein levels. MIP-2γ downregulation of GLT-1
expression was eliminated by PDTC, LY294002, KT5720,
and partially rescued by PD98059 (Figure 6), suggesting a
role for NF-κB, PI-3 K, PKA, and MEK/ERK.
MIP-2γ influences glutamate neurotoxicity
We used a neuron/astrocytes (N/A) co-culture system to
measure glutamate neurotoxicity. Neurons (at 11 days
in vitro) were co-cultured with differently treated astro-
cytes for 4 days and then treated with 50 μM glutamate
for 4 hours, after which astrocytes were removed and
the neuron survival was measured by LDH release and
MTT assays. Glutamate was more toxic to neurons in
co-culture with MIP-2γ-transfected or LPS-treated astro-
cytes than normal control astrocytes (Figure 7a, 7b),
but MIP-2γ siRNA-1 inhibited this change. Immu-
nocytochemistry using a MAP-2 antibody to detect
neurons confirmed these results (Figure 7c, 7d). Thus,
MIP-2γ overexpression in astrocytes makes neurons more
sensitive to glutamate toxicity by reducing GLT expression
and activity.
In addition, MIP-2γ did not change the effects of
astrocyte-conditioned media (AM) on neurons exposed
to glutamate toxicity (Figure 7e), suggesting that MIP-2γ
alone did not damage neurons nor make neurons more




























Figure 5 Effects of MIP-2γ overexpression on astrocyte
glutamate uptake. Results are expressed as the ratio of [3H]
glutamate uptake of transfected cultures over the value of the
control cultures ± SEM. Glutamate uptake capacity was decreased in
astrocytes transfected with pAAV-MIP-2γ-hrGFP plasmids (MIP-2γ)
compared with untreated cultures (control) or transfected with
pAAV-IRES-hrGFP (mock) vector. Astrocytes co-transfected with
pAAV-MIP-2γ-hrGFP plasmids and siRNA-1 (MIP-2γ + siRNA-1), but
not with pBS/U6-con (MIP-2γ + BS/U6-con), showed partially
restored glutamate uptake. n = 3, *P <0.05; **P <0.01 significantly
different from the value obtained in control (ANOVA followed by a
Bonferroni test). ANOVA, analysis of variance; MIP-2γ, macrophage
inflammatory protein-2γ; SEM, standard error of the mean; siRNA,
small interfering RNA.
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Discussion
The precise physiological function of chemokines in the
brain has not yet been fully determined. For example, we
have reported that a novel CXC chemokine, MIP-2γ, is
widely and constitutively expressed in normal brain [13]
and in EAE mice at the onset and relapse phases [14],
but little is known about its location or temporal pro-
duction. Here, we investigated the expression of MIP-2γ
in astrocytes, a major source of chemokines in the brain,
in response to stimulation with LPS or TNF-α, which
have been linked to CNS diseases from EAE to AIDS de-
mentia. Optimal MIP-2γ production occurred when
confluent astrocyte cultures were stimulated with 5 μg/
ml of LPS or 50 ng/ml TNF-α during a 48-hour culture,
with peak mRNA occurring after 6 hours of culture
(Figure 1b). Thus, MIP-2γ, like other cytokines, is pro-
duced by cells intrinsic to the brain: primarily astrocytes,
but potentially microglial cells and endothelial cells as
well.
Chemokines regulate leukocyte trafficking to the CNS,
but are also involved in pathophysiological processes
other than chemotaxis [21-23]. Here, we demonstrated
for the first time that MIP-2γ overexpression decreases
GLT-1 expression (mRNA and protein) and glutamate
uptake in primary cortical astrocytes, an effect that
could be blocked by MIP-2γ siRNA (Figure 3), but did
not affect GLAST expression. MIP-2γ overexpression
also reduced the levels of GLT-1 proteins in lipid rafts
(Figure 4), which are critical to transporter function
[19]. MIP-2γ overexpression actually enhanced caveolin-
1 levels. Activation of cAMP-dependent signaling path-
ways using dBcAMP or application of TGF-α can reduce
the expression of caveolin-1 and increase GLT-1 expres-
sion in rat astrocytes [19], suggesting a reciprocal regula-
tion of the two proteins in primary astrocytes.
Excessive glutamate stimulation is excitotoxic to
neurons, and astrocytes protect against glutamate


































Figure 6 Effect of pharmacological inhibitors on GLT-1 mRNA and protein expression. GLT-1 mRNA (a) and protein (b) expression in
astrocytes either untreated (control) or transfected with pAAV-MIP-2γ-hrGFP plasmids (MIP-2γ) in the absence or presence (+) of PDTC (100 μM),
LY294002 (10 μM), KT5720 (5 μM), or PD98059 (50 μM) for 48 hours. Individual experiments were performed three times with triplicate samples.
Results were expressed as fold of corresponding mean ± SEM after normalization to β-actin. *P <0.05; **P <0.01 compared with control group;
§ P <0.05; §§P <0.01 compared with MIP-2γ group; one-way ANOVA, Tukey test. ANOVA, analysis of variance; GLT-1, glutamate transporter; MIP-2γ,
macrophage inflammatory protein-2γ; SEM, standard error of the mean.





























Figure 7 (See legend on next page.)
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glutamate transporter activity. The overexpression of
MIP-2γ by astrocytes down-regulated GLT-1 expres-
sion and reduced glutamate uptake (Figure 5). We
found pharmacological inhibitors, specifically PDTC
(an inhibitor of NF-κB activation), LY294002 (a PI-3 K
inhibitor), KT5720 (a protein kinase A (PKA) inhibi-
tor), and PD98059 (a MEK/ERK inhibitor) blocked
MIP-2γ-mediated changes in GLT-1 expression. Taken
together, these results support the hypothesis that MIP-
2γ decreases GLT-1 activity in astrocytes through NF-
κB, PKA, PI3K, and partly through MEK/ERK signal
transduction pathways.
We used two model systems to evaluate whether
MIP-2γ overexpression changed glutamate neurotox-
icity. The first, a co-culture of astrocytes and neurons,
models their interaction to modulate effects of glutam-
ate. Neurons withdrawn from co-culture with MIP-2γ-
transduced astrocytes were more sensitive to glutamate
toxicity than mock-transduced cells. The second model
involves use of conditioned medium from astrocytes,
which did not alter neuronal sensitivity to glutamate
toxicity. These results suggest that MIP-2γ itself is not
toxic, but that the enhanced neuronal sensitivity to
excitotoxicity was caused by the decreased GLT-1 ac-
tivity induced by MIP-2γ.
In conclusion, chemokines and their receptors are
primarily involved in regulating CNS inflammatory pro-
cesses. MIP-2γ may provide a new pathway for neuron-
glia communications that are relevant to both normal
brain function and neuroinflammatory and neurodegen-
erative diseases. Furthermore, this research should reveal
the potential utility of chemokines and their receptors as
targets for therapeutic intervention in CNS disease.
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